Infectious Disease Advisor news story
Long-term antiretroviral therapy (ART) does not appear to reduce the elevated risk for anogenital cancer among people with HIV, with greater relative risks among those receiving ART for at least 10 years, according to study findings published in Clinical Infectious Diseases.
People with HIV have an increased risk for anogenital cancers, many of which are associated with HPV infection. Although ART can restore immune function, whether prolonged treatment reduces the risk for these malignancies remains unclear. Researchers evaluated the relationship between ART duration and the incidence of cervical, vulvar, anal, and penile cancers among adults with and without HIV.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.